Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration on Friday approved the newest version of LivaNova's Vagus Nerve Stimulation Therapy System.
Reno, Nev.-based tech startup Flirtey is developing a drone service that delivers portable defibrillators to local 911 callers who report symptoms of cardiac arrest, reports CNBC.
The U.S. could see several drug shortages within the next two to three weeks due to manufacturing issues in Puerto Rico, according to Scott Gottlieb, MD, head of the Food and Drug Administration.
Express Scripts will buy eviCore healthcare, a private medical benefits manager, for $3.6 billion.
The Food and Drug Administration on Monday approved Lupin's nadolol tablets.
Pfizer may spin off or sell its consumer healthcare division, according to The New York Times.
Here are four drug and medical device companies that made headlines in the past week.
Flexion Therapeutics on Friday earned Food and Drug Administration approval for Zilretta, an extended-release treatment for osteoarthritis knee pain.
Medtronic expects supply chain disruptions caused by Hurricane Maria to cost the company up to $250 million in the second quarter of fiscal year 2018, which ends Oct. 27.
The FDA approved an implantable device, Respicardia's Remede System, which helps fight moderate to severe cases of central sleep apnea, a condition where the brain doesn't send proper signals to the muscles that control breathing during sleep.